Search

everythinglearnresearchcommunity

for

Search:↓

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Understanding EGFR's role in skin is crucial for better treatments and managing side effects.

EGF receptor is crucial for skin health and its inhibitors can cause skin rashes.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

EGF and KGF signalling prevent hair follicle formation and promote skin cell development in mice.

TCDD disrupts skin stem cells, causing skin issues like chloracne.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

Increasing calcium sensing receptor speeds up skin and hair development in mice.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

EGFR is essential for organized skin nerve growth and branching.

Blocking EGFR in mice causes hair loss and skin changes.

Mice with human-like EGFR had growth issues, skin defects, heart problems, and unusual bone development.

EGFR is essential for normal hair development and follicle differentiation.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

Epidermal growth factor helps hair stem cells grow by activating specific cell pathways.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

Gefitinib can cause hair loss without scarring.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

EGFR inhibitors can cause skin issues like acne and dryness, but these can be managed without stopping treatment.

EGFR inhibitors often cause skin issues like acne and dryness, which can be managed with specific treatments.